Medtech company DermaSensor has claimed FDA approval for a handheld device, powered by artificial intelligence (AI), that can be used to detect skin cancer at the point of care. The eponymous ...

A researcher at a Scottish university has developed AI tools that could give people in remote areas of the world access to ...

Facial recognition is finally getting good enough to say something meaningful about our health. Are we ready for it?

A new imaging tool called the Vectra WB180 helps doctors detect and monitor melanoma with fewer biopsies by creating a ...

In trials over the course of one year, the system was tested in a clinical setting on 332 skin cancer samples at ...

A new cancer “fingerprint” can improve early detection of potentially deadly tumours, say scientists. Changes are detectable ...

Scientists plan the project to tackle radiation-induced lesions at the IAEA in Vienna (Photo: O. Belyakov/IAEA).

The internationally renowned cancer centre is working on the project – billed as the UK's first large-scale, AI-powered radiology platform for cancer research – with digital transformation ...

Cancer remains a leading cause of global mortality, largely due to late-stage diagnosis when therapeutic options are limited and prognosis is poor. Early detection and active disease monitoring enable ...

Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.

ASCO 2025 HIF-2α targeting as a new frontier in renal cell cancer (RCC) therapy, Von Hippel-Lindau (VHL) gene mutation, LITESPARK-005, metastatic clear cell RCC. belzutifan.